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Animal models and cell cultures have contributed new knowledge in biological sciences, including periodontology. Although
cultured cells can be used to study physiological processes that occur during the pathogenesis of periodontitis, the complex host
response fundamentally responsible for this disease cannot be reproduced in vitro. Among the animal kingdom, rodents, rabbits,
pigs, dogs, and nonhuman primates have been used to model human periodontitis, each with advantages and disadvantages.
Periodontitis commonly has been induced by placing a bacterial plaque retentive ligature in the gingival sulcus around the molar
teeth. In addition, alveolar bone loss has been induced by inoculation or injection of human oral bacteria (e.g., Porphyromonas
gingivalis) in different animal models. While animal models have provided a wide range of important data, it is sometimes difficult
to determine whether the findings are applicable to humans. In addition, variability in host responses to bacterial infection among
individuals contributes significantly to the expression of periodontal diseases. A practical and highly reproducible model that truly
mimics the natural pathogenesis of human periodontal disease has yet to be developed.
1. Introduction
1.1. Periodontitis. Periodontitis is a highly prevalent, chronic
immunoinflammatory disease of the periodontium that
results in progressive loss of gingival tissue, the periodontal
ligament, and adjacent supporting alveolar bone [1]. In
addition to its significant impact on human health, the
annual cost of periodontal therapy is estimated to exceed $14
billion in the USA [2]. Furthermore, periodontitis has been
associated with systemic diseases, such as cardiovascular
complications [3], rheumatoid arthritis [4], and adverse
pregnancy outcomes [5].
Chronic inflammation of the periodontium is initiated
by complex subgingival biofilms containing several likely
periodontal pathogens. The biofilm generally contains a
portion of the gram (−) negative anaerobic commensal
microbiota as well as opportunistic pathogens of the oral
cavity, including Porphyromonas gingivalis (P. gingivalis) [6].
In response to periodontal pathogens, polymorphonuclear
cells (PMNs) release destructive reactive oxygen species
(ROS), for example, superoxide, via the respiratory burst
[7–9], proteinases, and other factors that can damage host
tissues [10–12]. These molecules induce further oxidative
damage to gingival tissue, periodontal ligaments, and elicit
osteoclastic bone resorption [10, 13–15]. The secreted agents
also enhance the production of numerous proinflammatory
cytokines that contribute to the disease, including interleukin
(IL)-1ß, IL-6, and tumor necrosis factor (TNFα), among
a broad array of biomolecules that have consistently been
reported to be elevated in gingival crevicular fluid (GCF)
and tissues of periodontitis patients [16–18], rhesus mon-
keys [19], and dogs [20]. Levels of these proinflammatory
molecules are frequently reduced following periodontal
therapy [21, 22].
Because individuals are not equally susceptible to the
destructive effects of periodontal infections, periodontitis
is not only caused by bacterial infection but also may be
associated with host susceptibility [23, 24]. Variability in host
responses among individuals contributes significantly to the
expression of periodontal diseases [24]. Although human
cell cultures were found to be useful models for replicating
some aspects of the periodontal disease process at the cellular
level, information about the complex host response was not
prominent [25]. Thus, research into the host response using
animals is critically important in the analysis of periodontal
disease and development of improved treatments.
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1.2. Animal Models. Animal models have contributed to the
generation of new knowledge in biological sciences, includ-
ing periodontology [19, 20, 26–29]. Periodontal disease can
occur naturally or be experimentally induced in animals.
Various species have been used to study the pathogenesis of
periodontitis and to assess therapeutic modalities against the
disease. While animal models have provided a large amount
of data, it is sometimes difficult to determine whether the
findings are applicable to humans. Thus, a simple and
reproducible model that truly mimics human pathogenesis
of periodontal disease has yet to be discovered. This paper
reviews naturally and experimentally induced animal models
used to study different aspects of periodontal diseases.
1.3. Nonhuman Primates. Nonhuman primates have oral
structures and teeth similar to those of humans and have
naturally occurring dental plaque, calculus, oral microbial
pathogens (e.g., P. gingivalis), and periodontal disease. In
particular, rhesus monkeys (Macaca mulatta), cynomol-
gus monkeys (Macaca fascicularis), and baboons (Papio
anubis) are susceptible to naturally occurring periodontal
disease [30]. To accelerate periodontitis, however, plaque-
accumulating devices, such as orthodontic elastic ligatures
or sutures, are commonly placed apical to the interproximal
region around selected molars to promote plaque formation
[31]. Ligatures are changed at 1-2-week intervals until
periodontal pocket formation is confirmed by probing [32–
36]. The use of nonhuman primates was later modified to
include inoculation with human pathogens. Cynomolgus
monkeys with no previously detectible human pathogen P.
gingivalis were treated with the organism. About 5 months
later, infection by P. gingivalis was confirmed and plaque
formation leading to bone loss was observed [26].
Although periodontitis in primates most closely resem-
bles the human disease, the expense of and special husbandry
requirements for these animals limit their use in periodontal
studies. In addition, they are prone to infectious diseases such
as tuberculosis [30], which makes them a less practical model
for periodontal diseases.
1.4. Miniature Pigs. Miniature pigs have oral and max-
illofacial structures similar to those of humans in terms
of anatomy, physiology, and disease development [37].
The Minnesota miniature pig (minipig) was developed
about 60 years ago [38] and has been used extensively in
biomedical research [39]. After the age of 6 months, minipigs
usually develop gingivitis, manifested by inflamed gingival
tissue, accumulated plaque and calculus, and bleeding when
probed [37]. There is infiltration of inflammatory cells
in the gingival tissue that results in progression to severe
periodontal inflammation at 16 months of age with identical
histopathology to that seen in humans. Periodontitis in
minipigs is promoted in about 4–8 weeks using ligatures,
and in association with bacterial inoculations of P. gingivalis,
S. mutans, and A. actinomycetemcomitans [37]. Minipigs can
be suitable for periodontal as well as orofacial investigations.
However, minipigs are relatively expensive, with husbandry
issues and few studies to support their use.
1.5. Dogs. Dogs provide an appropriate model to study natu-
rally occurring gingivitis and periodontitis [20]. In dogs, the
subgingival plaque involves predominantly anaerobic gram
(−) negative cocci and rods, P. gingivalis and F. nucleatum,
similar to human bacteria [40, 41]. The severity of the disease
increases with age and frequently results in loss of tooth.
Susceptibility or resistance to periodontal disease in different
breeds is mainly dictated by genetic variations [42] rather
than the diet [43]. In addition, dogs are used for surgical
manipulations, including wound healing and regeneration in
periodontal pockets [44].
As a limitation of the natural periodontal diseases, the
extent and localization of periodontal lesions are not always
synchronized in dogs [45, 46]. In dogs, the complete width
of marginal gingiva is also affected rather than only the
tissue lateral to the gingival pocket wall. In addition, animal
care regulations, including daily companionship, exercise,
space, and maintenance, make use of dogs less desirable in
periodontal studies.
1.6. Rodent Models. Rodents provide some unique charac-
teristics to evaluate microbial and host responses to com-
plement primate and human periodontal studies. Rodents
have only one incisor and 3 molars in each quadrant.
Studies using rodents have elicited disease via placement
of ligatures in the gingival sulcus around the molar teeth
by increasing biofilm accumulation, as well as disrupting
the gingival epithelium, enhancing osteoclastogenesis and
bone loss [29]. In alternative models, these animals are
orally infected with select human pathogens, attempting to
document the virulence of these species in rodents [9, 47].
These approaches have also enabled the use of genetically
manipulated strains to focus on individual components of
the host response and to thereby describe their role in the
disease process [48, 49]. More recently, different investigators
have used gingival tissue inoculated with chemicals [28, 50],
microorganisms [51], or their products [52, 53] to elicit
periodontal disease.
1.6.1. Rats. Rats are often used in models of experimental
periodontitis because periodontal anatomy in the molar
region shares some similarities with that of humans. Fur-
thermore, rats are easy to handle and can be obtained
with different genomes and microbial status. There is clear
evidence from the literature demonstrating horizontal bone
loss in rats infected with Aggregatibacter (Actinobacillus)
actinomycetemcomitans [54–59] or P. gingivalis [56–60].
Periodontitis has been induced in rats by placing a bacterial
plaque retentive silk or cotton ligature in the gingival sulcus
around the molar teeth [61]. In addition, alveolar bone loss
has been induced by the injection of P. gingivalis [62].
Rice Rats. The swamp rice rat, or rice rat (Oryzomys
palustris), is a native American species found wildly in the
southern US [63]. These animals are highly susceptible to
periodontal disease, beginning as early as 2 weeks of age [64].
The gingival tissues become swollen, with pocket formation,
accumulation of debris, and ulceration at about 3 months
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of age. Alveolar bone resorption underneath the gingiva
causes the teeth to slide apart and eventually to exfoliate.
Heavy plaque formation occurs more on mandibular than on
maxillary teeth. Calculus and root-surface caries frequently
occur in older animals. The incidence of periodontal disease
has been shown to depend upon dietary factors [64, 65]. A
soft-powder diet with high-carbohydrate content is required
for the initiation of the disease in younger animals [64,
65], while high fat or protein diets reduced the severity of
disease [66]. Periodontitis in rice rats can be transmitted
by coprophagy [66, 67]. Early pathological findings include
an acute inflammatory response, with polymorphonuclear
cells infiltrating beneath the junctional and crevicular epithe-
lium and into the gingival sulcus, followed by “activated”
macrophages infiltrating into the affected epithelium. The
connective tissues are destroyed, and the epithelial attach-
ment migrates apically along the root surface, deepening the
pocket [63]. The advanced lesions present as a destruction of
the alveolar bone with fibrosis and granulation of the gingival
connective tissues and periodontal ligament space. Gram
(+) positive bacteria, S. sanguis, Actinomyces, and Lactobacilli
have been isolated at 5–9 weeks of age from the oral cavity
[68]. Unlike the chronic process in human periodontitis,
which takes many years, in the rice rat the disease progresses
to a chronic destruction of soft and hard tissue within a few
weeks. Rice rats have been used to evaluate the dietary effects
and some therapeutic modalities.
1.6.2. Mice
Baker Mouse Model. The Baker mouse model of periodonti-
tis has been used to measure alveolar bone resorption caused
by oral bacterial inoculums as an outcome for the clinical
presentation of periodontitis in humans [69]. To assess the
virulence of periodontal pathogens, specific pathogen-free
female BALB/c mice (10 weeks old) were orally infected
with strains of A. actinomycetemcomitans and/or P. gingivalis
[70–72]. Prior to infection, mice were given antibiotics
(sulfamethoxazole and trimethoprim) in their water for
about 10 days to suppress the normal oral microflora. Mice
were treated by oral gavage five times at 2-day intervals
with one type or an admixture of bacteria resuspended in
carboxymethylcellulose to establish the infection. Alveolar
bone loss was detected after 10 weeks. It was speculated
that P. gingivalis initiated experimental periodontitis, at least
in part, by modifying the endogenous subgingival biofilm
to acquire enhanced virulence [73]. Mice naturally develop
periodontitis starting at about 9 months of age with further
increases as a function of age, similar to human periodontitis.
This model, however, may not reproduce all aspects of
human periodontitis initiation and progression; the bacteria
used are one or two of at least 150 microbial types present
in any dental plaque biofilm. However mice can be utilized
to understand the host-parasite interaction [74]. Young mice
also can develop periodontitis caused by their own flora,
if their ability to control their indigenous bacteria is com-
promised by genetic defects in their phagocytes, although
the presence of antibiotics prevents the development of the
disease [75].
1 mm
Figure 1: Micro CT images of mouse maxilla (top) and mandible
(bottom) show 3 molars (curved arrow) and single incisor (arrow-
head). Courtesy of HS. Oz and DA. Puleo (unpublished data).
Chemically Induced Mouse Model. An alternative method
for inducing inflammation of oral tissues is by using trini-
trobenzene sulfonic acid (TNBS) or dextran sulphate sodium
(DSS) [28, 50]. These chemicals are often utilized to induce
acute (1 cycle) and chronic inflammation (3–5 cycles) in the
gut to evaluate progression of inflammatory bowel disease
(IBD) [76–79]. TNBS delivered rectally and DSS provided
orally elicit gastrointestinal inflammation, linked with the
natural microbiota of the murine gut [80–82]. DSS acts
to undermine the epithelial barrier and is an immune cell
activator, resulting in innate immune damage to the tissues.
TNBS appears to function as a hapten to modify autologous
proteins and induce a T-cell-mediated response, resulting in
autoimmune-like inflammatory responses [83]. In addition,
these compounds upregulate ROS to create a reproducible
model of IBD [76–83]. Oral delivery of DSS or TNBS for
an extended period of 18 weeks resulted in chronic oral
mucosal inflammation and alveolar bone loss [26, 50]. Mice
treated biweekly with DSS in their diet developed systemic
disease manifestations, including diarrhea and colitis and
dysregulated hepatic concentrations of antioxidants in a
time-dependent manner that correlated with a significant
increase in alveolar bone resorption.Mice treated orally
with TNBS 2 times/week developed no systemic clinical
symptoms [28, 50]. Oral administration of TNBS resulted
in a localized action on periodontal tissues with alveolar
bone loss observed in both maxilla and mandibles with
progression in a time-dependent manner. In contrast, TNBS
injection into gingival tissues caused a localized but severe
and acute infiltration of inflammatory cells, granuloma
formation, and rapid and extensive alveolar bone loss.
Implementation of these inflammatory bone resorption
models will enable determination of ROS contributions to
inflammatory disease lesions in the oral cavity [28, 50].
Mice have 3 molars and 1 rootless incisor in each quadrant
(Figure 1) and provide minute amount of gingival tissue.
Therefore, relatively large numbers of animals per group are
needed.
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Table 1: Advantages and disadvantages of select animal models for studying periodontal disease development.
Animal model Advantages Disadvantages
Nonhuman primates
Similar dental structure, microflora, and disease
to humans’. Natural or experimentally induced
periodontitis.
Very expensive, with ethical and husbandry issues
Dogs
Develop natural or experimental periodontitis
similar to humans
Relatively expensive, need special daily care,
husbandry issues. Dentition different from humans.
Miniature pigs
Dental structure and periodontitis have some
similarity to humans’. Natural or experimentally
induced periodontitis.
Relatively expensive, husbandry issues; relatively
few studies
Ferrets
Naturally or experimentally induced disease
with similarity to humans’
Some husbandry issues
Rodents
Experimentally induced disease. Similar molar
structure to humans’. Inexpensive model
Naturally resistant to periodontitis. Different
microbiota from humans’. Small size and therefore
amount of tissue for analysis. Large number of
animals needed
Murine Incisor Abscess Model. Rodent incisors have no roots
and are continually erupting. To induce a gum pocket
abscess model, outbred ICR mice (3–6 weeks old) were
injected for 3 days into the gums of lower incisors with F.
nucleatum that naturally does not colonize mice [84]. The
swelling at the site of the injection suggested a short-term
F. nucleatum infection. Histological examination using H&E
staining showed granuloma formation within the inflamed
gum. This model needs repeated injections of the bacteria
and has a limited use in studying gum pocket abscess to
mimic chronic halitosis caused by microbial infection.
Murine Back Abscess Model. The murine back abscess model
has been used to investigate the interactions of both
oral microbial species and host responses to various oral
pathogens as monomicrobial infections leading to soft tissue
destruction (e.g., P. gingivalis [85–87] and Treponema denti-
cola [88]). Mixed infections (P. gingivalis and F. nucleatum
[89]; P. gingivalis and A. actinomycetemcomitans [90]) have
been shown to result in formation of larger abscess compared
to a monoinfection [89]. Coinfection with S. constellatus and
F. nucleatum caused death in mice, while monoinfection with
these organisms was not lethal [91]. In addition, the mouse
subcutaneous chamber model has been used to study host-
bacteria interactions and to determine virulence variations
among P. gingivalis strains leading to tissue damage and
invasion [92]. Although, the lesions are not located in
the oral cavity, this model has some value for examining
bacterially induced infections/coinfections that result in soft
tissue destruction.
1.7. Other Animals
1.7.1. Horses. Common naturally occurring oral diseases in
horses include buccal abrasions, calculus, gingival recession,
and periodontal pockets. According a recent equine survey,
the prevalence of periodontal pockets and gingival recession
is highest in older horses and mostly associated with other
dental disorders and tooth loss [93]. Because of their size and
husbandry considerations, horses are not a practical model
for basic science studies of periodontitis or for testing of
potential therapies.
1.7.2. Rabbits. Characterization of the oral microorganisms
in rabbits showed numerous pathogenic bacteria, including
F. nucleatum, P. heparinolytica, Prevotella spp., P. micros, S.
milleri group, A. israelii, and A. haemolyticum, which is
somehow consistent with the flora related to periodontal
disease in humans [94]. Rabbits have been used for creation
of surgically induced periodontal defect and to study peri-
odontal regeneration, but they have been found less suitable
for regeneration of periodontal ligament [94, 95].
1.7.3. Ferrets. Ferrets (Mustela putorius) naturally develop
calculus and periodontal disease similar to humans [96, 97].
Unlike rodents, calculus formation in ferrets does not depend
on the diet and can be scored in live ferrets [96]. Ferrets
are a suitable model to study calculus; however, they can
easily escape from standard cages and they need special
maintenance.
1.7.4. Hamsters. Hamsters have a dental formula similar to
that of rats, and they develop experimental periodontitis
using ligatures around the molar teeth [98–100]. In addition,
hamsters have buccal pouches lined with stratified squamous
epithelium that are useful for studying oral carcinoma [101].
The disease development is very similar to rats.
2. Conclusion
Each animal model for periodontal disease has advantages
and disadvantages (summarized in Table 1). Several show
similarities to human disease. While nonhuman primates
are most similar to the human condition, their cost and
husbandry issues preclude widespread use for both basic
science and therapeutic studies of periodontal disease.
Rodents are less expensive and easier to handle; however,
they do not reproduce all aspects of human periodontitis
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progression. For example, ligatures and/or seeding with
exogenous (human) pathogens comprising only one or two
from hundreds of microbes that constitute dental plaque
biofilm are often needed to induce disease. In addition,
rodents have their unique dental anatomical differences.
Nonetheless, rats and mice are useful for understanding
some aspects of the host-microbe interaction and therapies.
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